Table of Contents
Hundreds of thousands of spine fusions are performed each year, but implant choice is still often limited to standard sizes. That is the gap patient-specific spine surgery is trying to close, and Carlsmed is building for that shift with its AI-enabled personalized platform.
In published data across 500+ patients, 82% of personalized levels achieved target alignment within 5°, and 96% showed zero subsidence at one year.
Commercially, the company reported $50.5M in 2025 revenue, up 85.9% year over year, with 75.3% gross margins.
More recently, it expanded its ecosystem with the first bilateral posterior lumbar procedure, the first corra cervical plating case, and a reported 6-day lead time for aprevo implants.
At JPM 2026, Onyx sat down with CEO Mike Cordonnier to find out more.
I hope you enjoy watching!
Yours sincerely,
Dr. Adil Ali
Coming up: Cell & Gene Leaders Live, Sun 15 Nov at The Shard · London Life Sciences Week Guide, 15–19 Nov 2026 ·
Comments